O1‐10‐03: an Active Anti‐AB40 Vaccine (ABVAC40) Proved to be Safe and Immunogenic in the Phase i Clinical Trial. (1st July 2016) - Lacosta, Ana M.; Pérez-Grijalba, Virginia; Marcos, Ivan; Sarasa, Leticia; San José, Itziar; Núñez, Laura; Boada, Mercè; Tárraga, Lluis; Ruiz, Agustin; Pesini, Pedro; Sarasa, Manuel